PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$21.42M
Total Shares
15.98M
Net Share Change
+2.23M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Patient Capital Management
$21.42M15.98M shares
ADD+2.23M(+16.2%)